Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1-10 of 44

Page
per page
  1. Riluzole
    A8513 Riluzole
    Target: Voltage-gated Sodium (NaV) Channels|glutamate release
    Summary: Sodium channel protein inhibitor
      ≥23.4 mg/mL
  2. Dibucaine (Cinchocaine) HCl
    A8407 Dibucaine (Cinchocaine) HCl
    Summary: Sodium channel inhibitor
      ≥11.9 mg/mL
  3. A-803467
    B2277 A-803467
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: NaV1.8 channel blocker,potent and selective
      insoluble in H2O; ≥13.95 mg/mL
  4. Flecainide acetate
    A3418 Flecainide acetate
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: Antiarrhythmic drug
      ≥23.7 mg/mL
  5. S0859
    A3783 S0859
    Summary: NBC inhibitor,potent and selective
      ≥45 mg/mL
  6. Oxcarbazepine
    B2279 Oxcarbazepine
    Summary: BTX inhibitor
      insoluble in H2O; insoluble in EtOH; ≥9.1 mg/mL
  7. Carbamazepine
    B1390 Carbamazepine
    Summary: Inhibitor of neuronal voltage-gated Na+ channels
      insoluble in H2O; ≥10.85 mg/mL
  8. Ambroxol HCl
    B2267 Ambroxol HCl
    Summary: TTX-resistant Na+ currents inhibitor
      insoluble in EtOH; ≥164.6 mg/mL
  9. Lamotrigine
    B2249 Lamotrigine
     1 Citation
    Target: 5-HT receptors|sodium channel
    Summary: 5-HT inhibitor， sodium channel blocker
      insoluble in H2O; ≥12.3 mg/mL
  10. Ouabain
    B2270 Ouabain
    Summary: selective Na+/K+-ATPase inhibitor
      ≥72.9 mg/mL

Items 1-10 of 44

Page
per page